Drug recall · April 29, 2015
Bromfenac Sodium active pharmaceutical ingredient recall
Why: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bromfenac Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
- Lots / codes
All lots repackaged and distributed between 01/05/12 to 02/12/15
- Quantity
- 70 grams
- Company
- Attix Pharmaceuticals, Toronto
- Distribution
- Nationwide to compounding pharmacies and research organizations.
- Initiated
- November 14, 2014 · Voluntary: Firm initiated
- Classified
- April 20, 2015
- Reported
- April 29, 2015
- Ended
- October 7, 2015
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bromfenac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.